BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND DUX4L1, DUX4, P0CJ90, P0CJ89, P0CJ88, P0CJ86, P0CJ85, 22947 AND Prognosis
14 results:

  • 1. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
    Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
    J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
    Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
    Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia.
    Yu CH; Jou ST; Su YH; Coustan-Smith E; Wu G; Cheng CN; Lu MY; Lin KH; Wu KH; Chen SH; Huang FL; Chang HH; Wang JL; Yen HJ; Li MJ; Chou SW; Ho WL; Liu YL; Chang CC; Lin ZS; Lin CY; Chen HY; Ni YL; Lin DT; Lin SW; Yang JJ; Ni YH; Pui CH; Yu SL; Yang YL
    Cancer; 2023 Mar; 129(5):790-802. PubMed ID: 36537587
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic Leukemia.
    Yu CH; Wu G; Chang CC; Jou ST; Lu MY; Lin KH; Chen SH; Wu KH; Huang FL; Cheng CN; Chang HH; Hedges D; Wang JL; Yen HJ; Li MJ; Chou SW; Hung CT; Lin ZS; Lin CY; Chen HY; Ni YL; Hsu YC; Lin DT; Lin SW; Yang JJ; Pui CH; Yu SL; Yang YL
    J Mol Diagn; 2022 Nov; 24(11):1195-1206. PubMed ID: 35963521
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. N-terminus dux4-immunohistochemistry is a reliable methodology for the diagnosis of dux4-fused B-lymphoblastic leukemia/lymphoma (N-terminus dux4 IHC for dux4-fused B-ALL).
    Siegele BJ; Stemmer-Rachamimov AO; Lilljebjorn H; Fioretos T; Winters AC; Dal Cin P; Treece A; Gaskell A; Nardi V
    Genes Chromosomes Cancer; 2022 Aug; 61(8):449-458. PubMed ID: 35218117
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association of Genetic Ancestry With the Molecular Subtypes and prognosis of Childhood Acute Lymphoblastic Leukemia.
    Lee SHR; Antillon-Klussmann F; Pei D; Yang W; Roberts KG; Li Z; Devidas M; Yang W; Najera C; Lin HP; Tan AM; Ariffin H; Cheng C; Evans WE; Hunger SP; Jeha S; Mullighan CG; Loh ML; Yeoh AEJ; Pui CH; Yang JJ
    JAMA Oncol; 2022 Mar; 8(3):354-363. PubMed ID: 35084434
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Distinct clinical characteristics of dux4- and PAX5-altered childhood B-lymphoblastic leukemia.
    Li Z; Lee SHR; Chin WHN; Lu Y; Jiang N; Lim EH; Coustan-Smith E; Chiew KH; Oh BLZ; Koh GS; Chen Z; Kham SKY; Quah TC; Lin HP; Tan AM; Ariffin H; Yang JJ; Yeoh AE
    Blood Adv; 2021 Dec; 5(23):5226-5238. PubMed ID: 34547766
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. dux4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.
    Novakova M; Zaliova M; Fiser K; Vakrmanova B; Slamova L; Musilova A; Brüggemann M; Ritgen M; Fronkova E; Kalina T; Stary J; Winkowska L; Svec P; Kolenova A; Stuchly J; Zuna J; Trka J; Hrusak O; Mejstrikova E
    Haematologica; 2021 Aug; 106(8):2066-2075. PubMed ID: 32646889
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of immunophenotypic characteristics on genetic subgrouping in childhood acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) study L04-16.
    Ohki K; Takahashi H; Fukushima T; Nanmoku T; Kusano S; Mori M; Nakazawa Y; Yuza Y; Migita M; Okuno H; Morimoto A; Yoshino H; Kato M; Hayashi Y; Manabe A; Ohara A; Hasegawa D; Inukai T; Tomizawa D; Koh K; Kiyokawa N;
    Genes Chromosomes Cancer; 2020 Oct; 59(10):551-561. PubMed ID: 32368831
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Refined detection and phasing of structural aberrations in pediatric acute lymphoblastic leukemia by linked-read whole-genome sequencing.
    Nordlund J; Marincevic-Zuniga Y; Cavelier L; Raine A; Martin T; Lundmark A; Abrahamsson J; Norén-Nyström U; Lönnerholm G; Syvänen AC
    Sci Rep; 2020 Feb; 10(1):2512. PubMed ID: 32054878
    [TBL] [Abstract] [Full Text] [Related]  

  • 11.
    Zaliova M; Potuckova E; Hovorkova L; Musilova A; Winkowska L; Fiser K; Stuchly J; Mejstrikova E; Starkova J; Zuna J; Stary J; Trka J
    Haematologica; 2019 Jul; 104(7):1407-1416. PubMed ID: 30630977
    [No Abstract]    [Full Text] [Related]  

  • 12. High STAP1 expression in dux4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Bakker M; Hoogkamer AQ; Boer JM; Hartman QJ; Stalpers F; Escherich G; de Haas V; de Groot-Kruseman HA; Pieters R; den Boer ML
    Sci Rep; 2018 Jan; 8(1):693. PubMed ID: 29330417
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Acute lymphoblastic leukemia of adolescents and young adults: from the viewpoint of physicians].
    Yasuda T; Hayakawa F
    Rinsho Ketsueki; 2017; 58(8):1031-1037. PubMed ID: 28883266
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.
    Marincevic-Zuniga Y; Dahlberg J; Nilsson S; Raine A; Nystedt S; Lindqvist CM; Berglund EC; Abrahamsson J; Cavelier L; Forestier E; Heyman M; Lönnerholm G; Nordlund J; Syvänen AC
    J Hematol Oncol; 2017 Aug; 10(1):148. PubMed ID: 28806978
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.